MSLN and Patent ductus arteriosus: Contrasting with endogenous T cells of unknown antigen specificity that are excluded from PDA, we showed that T cells engineered to express a high affinity mesothelin (Msln)-specific TCR preferentially accumulate in tumors of KPC mice (53).